Evogene Ltd. - Regulatory Filings 2019

Lavie Bio Announces Advancement in its Product Development Pipeline for Wheat Bio-Stimulants false


	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	18/11/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-099018	Time of broadcast: 12:20 12:12:49

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onLavie Bio Announces Advancement in its Product Development Pipeline for Wheat Bio-Stimulants

Lavie_Wheat_Biostimulants_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: -1	Date of revision of form structure: 29/10/2019
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected] Company site: www.evogene.com

Previous names of reporting entity:

Name of the Signatory: Bartov Pinto Amitai Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company:
Address: Gad Feinstein 13 , Rehovot 7612002 Telephone: 08-9311962 Facsimile: 08-9466724 E-mail: [email protected] 1

AI assistant